Ronald J. Prentki
Overview
Ronald J. Prentki received an average of $1M in total compensation, including $276K in salary, at Heron Therapeutics from 2008 to 2010.
Source: SEC filings on June 3, 2011 and April 23, 2010.
Related executives
We found 22 more executives who work or worked at Heron Therapeutics.
Craig Collard
Heron Therapeutics
Chief Executive Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics